INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS to TREATMENT for SARCOPENIC OBESITY
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs IMMUNA (Primary)
- Indications Sarcopenia
- Focus Expanded access; Therapeutic Use
- Acronyms STEM-META-EAP
- Sponsors Immunis
- 29 Jan 2025 New trial record